Cmed Presents New Generation Technology to Speed and Streamline Clinical Trials at Dpharm Europe

Written by Cmed

Cmed, an innovative technology-led CRO, today announced its participation at Dpharm Europe: Disruptive Innovations to Advance Clinical Trials (8-9 February 2017, London), where it will showcase its cloud-based, new generation clinical data suite, encapsia®. Graham Belgrave, Chief Operations Officer at Cmed, will introduce encapsia® in the “Innovative Sources & Solutions: Quickfire Disruptors” session on Wednesday 8 February between 4:30pm and 5:00pm, and highlight how a truly flexible, new seamless approach can simplify and streamline clinical trials.

Available now, encapsia® heralds a new era for clinical trials by providing a much needed solution to the ever-rising complexity and cost of clinical research. With new and better options to collect, query, clean, visualize and analyze clinical data in real time, all within one clinical data suite, encapsia® allows Cmed to significantly enhance the delivery of clinical trials – saving time and money.

Throughout the conference, Cmed will demonstrate some of the exciting capabilities of encapsia® for increasing trial efficiency, improving timelines and reducing cost, at booth #2. encapsia® is unlike any of the existing “last generation” systems and offers integrated, multiple ways for data capture, including mobile eSource, multi-media capture via an iPad and web eDC via a very modern, fast user interface. Powerful, configurable visualizations give live actionable insights and immediate analytics of a trial, allowing issues and trends to be identified and analyzed easily and rapidly.

Attendees will also be able to find out about Cmed’s full suite of services, which ranges from full-service to stand-alone solutions and functional services, such as biometrics, as well as learn about the company’s significant experience in bringing innovation to the design and conduct of complex and demanding clinical trials.

To schedule a meeting with the Cmed team during Dpharm Europe, contact Louise Holliday, Director of Business Development, at lholliday@cmedresearch.com.